Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Increased by Toronto Dominion Bank

Toronto Dominion Bank raised its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 35.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 482,521 shares of the pharmacy operator's stock after acquiring an additional 126,191 shares during the period. Toronto Dominion Bank owned approximately 0.06% of Walgreens Boots Alliance worth $4,502,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Swedbank AB raised its stake in Walgreens Boots Alliance by 45.3% during the 4th quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator's stock valued at $5,559,000 after acquiring an additional 185,762 shares in the last quarter. Merit Financial Group LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $326,000. Orca Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $322,000. Sound Income Strategies LLC raised its stake in shares of Walgreens Boots Alliance by 4.8% in the 4th quarter. Sound Income Strategies LLC now owns 507,213 shares of the pharmacy operator's stock worth $4,732,000 after buying an additional 23,373 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth $9,685,000. Institutional investors own 58.59% of the company's stock.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina purchased 832,258 shares of the stock in a transaction dated Sunday, April 27th. The shares were acquired at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the acquisition, the chairman now owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. This represents a 0.57% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 17.50% of the stock is owned by insiders.

Walgreens Boots Alliance Stock Down 0.4%

Shares of Walgreens Boots Alliance stock opened at $11.18 on Thursday. The stock's fifty day moving average is $11.02 and its 200-day moving average is $10.39. The firm has a market capitalization of $9.67 billion, a PE ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $16.74.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The company had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.20 earnings per share. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on WBA. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. StockNews.com began coverage on Walgreens Boots Alliance in a research note on Wednesday. They issued a "hold" rating on the stock. Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Finally, Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.